Skip to main content
SpringerLink
Log in

Diabetes and obesity: the twin epidemics

  • Market Analysis
  • Published:

From Nature Medicine

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Worldwide diabetic population (in millions).

Simon Fenwick

Figure 2: Estimated financial costs of diabetes in the US.

Simon Fenwick

Figure 3: Historical and forecast growth of the global insulin market.

Simon Fenwick

Figure 4: Historical and forecasted growth of the global oral antidiabetic market.

Simon Fenwick

Figure 5: Prevalence of obesity in US adults.

Simon Fenwick

Figure 6: Rimonabant (Acomplia) looks set to grow the obesity market.

Simon Fenwick

Author information

Authors and Affiliations

  1. Senior Consultants (Life Sciences), Wood Mackenzie, 5th Floor, Tower 42, International Finance Centre, 25 Old Broad St, London, EC2N 1HN, UK

    Simon Smyth & Andrew Heron

Authors
  1. Simon Smyth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrew Heron
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew Heron.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smyth, S., Heron, A. Diabetes and obesity: the twin epidemics. Nat Med 12, 75–80 (2006). https://doi.org/10.1038/nm0106-75

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0106-75

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation